| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in financing activities | -4,247,152 | -4,130,684 |
| Net change in cash and restricted cash | 15,311,425 | 10,426,954 |
| Cash and cash equivalents at beginning of period | 11,769,161 | - |
| Cash and cash equivalents at end of period | 27,080,586 | - |
ELITE PHARMACEUTICALS INC NV (ELTP)
ELITE PHARMACEUTICALS INC NV (ELTP)